MEDP
Income statement / Annual
Last year (2023), Medpace Holdings, Inc.'s total revenue was $1.89 B,
an increase of 29.17% from the previous year.
In 2023, Medpace Holdings, Inc.'s net income was $282.81 M.
See Medpace Holdings, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$1.89 B
|
$1.46 B
|
$1.14 B
|
$925.93 M
|
$860.97 M
|
$704.59 M
|
$436.15 M
|
$421.58 M
|
$359.06 M
|
$290.04 M
|
| Cost of Revenue |
$1.36 B |
$1.03 B |
$814.22 M |
$647.20 M |
$615.27 M |
$489.06 M |
$261.46 M |
$249.47 M |
$202.67 M |
$156.31 M |
| Gross Profit |
$524.51 M |
$432.44 M |
$328.16 M |
$278.73 M |
$245.70 M |
$215.53 M |
$174.69 M |
$172.11 M |
$156.39 M |
$133.73 M |
| Gross Profit Ratio |
0.28 |
0.3 |
0.29 |
0.3 |
0.29 |
0.31 |
0.4 |
0.41 |
0.44 |
0.46 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$159.85 M
|
$130.10 M
|
$107.22 M
|
$91.46 M
|
$94.55 M
|
$75.68 M
|
$63.36 M
|
$61.51 M
|
$56.60 M
|
$39.37 M
|
| Selling & Marketing
Expenses |
$1.50 M
|
$1.30 M
|
$1.20 M
|
$700,000.00
|
$700,000.00
|
$800,000.00
|
$600,000.00
|
$600,000.00
|
$400,000.00
|
$300,000.00
|
| Selling, General &
Administrative Expenses |
$161.35 M
|
$131.40 M
|
$108.42 M
|
$92.16 M
|
$95.25 M
|
$75.68 M
|
$63.36 M
|
$61.51 M
|
$57.00 M
|
$39.67 M
|
| Other Expenses |
$26.33 M |
$22.34 M |
$21.12 M |
$19.53 M |
$23.19 M |
$1.06 M |
-$354,000.00 |
-$423,000.00 |
$174,000.00 |
$0.00 |
| Operating Expenses |
$187.68 M |
$153.74 M |
$129.54 M |
$111.68 M |
$118.43 M |
$114.48 M |
$109.83 M |
$119.62 M |
$126.52 M |
$128.54 M |
| Cost And Expenses |
$1.55 B |
$1.18 B |
$943.76 M |
$758.88 M |
$733.71 M |
$603.54 M |
$371.29 M |
$369.09 M |
$329.18 M |
$284.85 M |
| Interest Income |
$0.00 |
$2.91 M |
$105,000.00 |
$307,000.00 |
$1.57 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$26.46 M |
| Interest Expense |
$488,000.00 |
$2.91 M |
$105,000.00 |
$307,000.00 |
$1.57 M |
$8.16 M |
$7.56 M |
$19.38 M |
$27.26 M |
$0.00 |
| Depreciation &
Amortization |
$26.33 M
|
$40.36 M
|
$37.41 M
|
$33.45 M
|
$23.19 M
|
$38.80 M
|
$46.47 M
|
$58.11 M
|
$69.52 M
|
$68.06 M
|
| EBITDA |
$363.15 M
|
$301.04 M
|
$219.73 M
|
$186.57 M
|
$150.45 M
|
$140.91 M
|
$110.98 M
|
$110.60 M
|
$102.60 M
|
$94.06 M
|
| EBITDA Ratio |
0.19 |
0.21 |
0.19 |
0.2 |
0.17 |
0.2 |
0.25 |
0.26 |
0.28 |
0.32 |
| Operating Income Ratio
|
0.18
|
0.19
|
0.17
|
0.18
|
0.15
|
0.14
|
0.17
|
0.14
|
0.1
|
0.09
|
| Total Other
Income/Expenses Net |
-$1.14 M
|
$4.16 M
|
$3.24 M
|
$1.49 M
|
-$2.43 M
|
-$7.10 M
|
-$7.91 M
|
-$30.53 M
|
-$28.39 M
|
-$47.26 M
|
| Income Before Tax |
$335.68 M |
$282.86 M |
$201.85 M |
$168.53 M |
$124.83 M |
$93.95 M |
$56.95 M |
$21.96 M |
-$7.83 M |
-$21.26 M |
| Income Before Tax Ratio
|
0.18
|
0.19
|
0.18
|
0.18
|
0.14
|
0.13
|
0.15
|
0.06
|
-0.02
|
-0.07
|
| Income Tax Expense |
$52.87 M |
$37.49 M |
$20.00 M |
$23.15 M |
$24.39 M |
$20.77 M |
$17.82 M |
$8.53 M |
$843,000.00 |
$5.69 M |
| Net Income |
$282.81 M |
$245.21 M |
$181.39 M |
$144.93 M |
$100.16 M |
$72.89 M |
$39.03 M |
$13.39 M |
-$8.67 M |
-$15.57 M |
| Net Income Ratio |
0.15 |
0.17 |
0.16 |
0.16 |
0.12 |
0.1 |
0.1 |
0.04 |
-0.03 |
-0.05 |
| EPS |
9.2 |
7.57 |
5.06 |
4.07 |
2.79 |
2.05 |
1 |
0.38 |
-0.28 |
-0.53 |
| EPS Diluted |
8.88 |
7.28 |
4.81 |
3.84 |
2.67 |
1.97 |
0.98 |
0.37 |
-0.28 |
-0.53 |
| Weighted Average Shares
Out |
$30.72 M
|
$32.39 M
|
$35.86 M
|
$35.64 M
|
$35.88 M
|
$35.55 M
|
$39.06 M
|
$35.69 M
|
$39.63 M
|
$29.43 M
|
| Weighted Average Shares
Out Diluted |
$31.84 M
|
$33.67 M
|
$37.70 M
|
$37.71 M
|
$37.58 M
|
$36.91 M
|
$39.84 M
|
$36.33 M
|
$39.63 M
|
$29.43 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
